New combinations in metastatic colorectal cancer: what are our expectations?
Publication
, Journal Article
Hurwitz, H
Published in: Oncologist
May 2005
Duke Scholars
Published In
Oncologist
DOI
ISSN
1083-7159
Publication Date
May 2005
Volume
10
Issue
5
Start / End Page
320 / 322
Location
England
Related Subject Headings
- Oxaliplatin
- Organoplatinum Compounds
- Oncology & Carcinogenesis
- Irinotecan
- Humans
- Fluorouracil
- Colorectal Neoplasms
- Cetuximab
- Camptothecin
- Bevacizumab
Citation
APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H. (2005). New combinations in metastatic colorectal cancer: what are our expectations? Oncologist, 10(5), 320–322. https://doi.org/10.1634/theoncologist.10-5-320
Hurwitz, Herbert. “New combinations in metastatic colorectal cancer: what are our expectations?” Oncologist 10, no. 5 (May 2005): 320–22. https://doi.org/10.1634/theoncologist.10-5-320.
Hurwitz H. New combinations in metastatic colorectal cancer: what are our expectations? Oncologist. 2005 May;10(5):320–2.
Hurwitz, Herbert. “New combinations in metastatic colorectal cancer: what are our expectations?” Oncologist, vol. 10, no. 5, May 2005, pp. 320–22. Pubmed, doi:10.1634/theoncologist.10-5-320.
Hurwitz H. New combinations in metastatic colorectal cancer: what are our expectations? Oncologist. 2005 May;10(5):320–322.
Published In
Oncologist
DOI
ISSN
1083-7159
Publication Date
May 2005
Volume
10
Issue
5
Start / End Page
320 / 322
Location
England
Related Subject Headings
- Oxaliplatin
- Organoplatinum Compounds
- Oncology & Carcinogenesis
- Irinotecan
- Humans
- Fluorouracil
- Colorectal Neoplasms
- Cetuximab
- Camptothecin
- Bevacizumab